D Honeybourne
Overview
Explore the profile of D Honeybourne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barr H, Halliday N, Barrett D, Williams P, Forrester D, Peckham D, et al.
J Cyst Fibros
. 2017 Oct;
16(6):e21.
PMID: 29079141
No abstract available.
2.
Mutagi A, Nash E, Cameron S, Abbott G, Agostini P, Whitehouse J, et al.
J Hosp Infect
. 2012 May;
81(2):104-8.
PMID: 22579442
Background: There is currently little evidence regarding potential risks of bacterial contamination of non-invasive ventilation (NIV) devices used by cystic fibrosis (CF) patients. Aim: The aim of this study was...
3.
Dowman J, WATSON D, Loganathan S, Gunson B, Hodson J, Mirza D, et al.
Am J Transplant
. 2012 Jan;
12(4):954-64.
PMID: 22225648
Early liver transplant (LT) has been advocated for patients with cystic fibrosis liver disease (CFLD) and evidence of deterioration in nutritional state and respiratory function to prevent further decline. However,...
4.
Mukherjee R, Whitehouse J, Honeybourne D
Thorax
. 2008 Apr;
63(5):473.
PMID: 18443168
No abstract available.
5.
Andrews J, Honeybourne D, Ashby J, Jevons G, Fraise A, Fry P, et al.
J Antimicrob Chemother
. 2007 Jul;
60(3):677-80.
PMID: 17623694
Objectives: A validated microbiological assay was used to measure concentrations of iclaprim (AR-100) in plasma, bronchial mucosa (BM), alveolar macrophages (AM) and epithelial lining fluid (ELF) after a single 1.6...
6.
Banerjee D, Honeybourne D
Curr Opin Infect Dis
. 2006 Oct;
12(6):543-7.
PMID: 17035819
Chronic obstructive pulmonary disease is a disease state characterized by the presence of airflow obstruction due to chronic bronchitis and/or emphysema. The airflow obstruction is generally progressive. In the past...
7.
Rajasekaran A, Silvey D, Leung B, Honeybourne D, Cayton R, Reynolds J, et al.
Postgrad Med J
. 2006 Jun;
82(968):414-6.
PMID: 16754713
No abstract available.
8.
Chambers D, Scott F, Bangur R, Davies R, Lim A, Walters S, et al.
Eur Respir J
. 2005 Oct;
26(4):651-6.
PMID: 16204596
Cross-infection with Pseudomonas aeruginosa is an emerging issue in the care of patients with cystic fibrosis (CF). This study sought to determine the extent of, and patient factors associated with,...
9.
Banerjee D, Khair O, Honeybourne D
Respir Med
. 2005 Feb;
99(2):208-15.
PMID: 15715188
Background: Chronic obstructive pulmonary disease (COPD) is characterised by airway inflammation, poor health status and recurrent infective exacerbations. Macrolide antibiotics have been shown to improve symptoms and exacerbation rate in...
10.
Banerjee D, Khair O, Honeybourne D
Eur Respir J
. 2004 Jun;
23(5):685-91.
PMID: 15176680
Chronic obstructive pulmonary disease (COPD) is characterised by sputum production, bacterial colonisation, neutrophilic bronchial airway inflammation and poor health status. The aim of this study was to determine the impact...